S I D E B A R
Format
Items per page
Sort by

Download:

Choose Destination

Search results

Items: 1 to 100 of 321

VariationLocationGene(s)Condition(s)Clinical significance
(Last reviewed)
Review status
1.
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
2.
AGXTPrimary hyperoxaluria, type IPathogenic
(Sep 1, 2004)
no assertion criteria provided
3.
GRCh37:
Chr2:241808237
GRCh38:
Chr2:240868820
AGXTPrimary hyperoxaluriaLikely benign
(Jun 14, 2016)
criteria provided, single submitter
4.
GRCh37:
Chr2:241808260
GRCh38:
Chr2:240868843
AGXTPrimary hyperoxaluriaLikely benign
(Jun 14, 2016)
criteria provided, single submitter
5.
GRCh37:
Chr2:241808269
GRCh38:
Chr2:240868852
AGXTPrimary hyperoxaluriaUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
6.
GRCh37:
Chr2:241808284-241808285
GRCh38:
Chr2:240868867-240868868
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
7.
GRCh37:
Chr2:241808284
GRCh38:
Chr2:240868867
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
8.
GRCh37:
Chr2:241808285
GRCh38:
Chr2:240868868
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
9.
GRCh37:
Chr2:241808304
GRCh38:
Chr2:240868887
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
10.
GRCh37:
Chr2:241808308
GRCh38:
Chr2:240868891
AGXTPrimary hyperoxaluria, type I, not specifiedConflicting interpretations of pathogenicity
(Mar 28, 2016)
criteria provided, conflicting interpretations
11.
GRCh37:
Chr2:241808309
GRCh38:
Chr2:240868892
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
12.
GRCh37:
Chr2:241808310
GRCh38:
Chr2:240868893
AGXTnot specifiedUncertain significance
(Feb 13, 2016)
criteria provided, single submitter
13.
GRCh37:
Chr2:241808310
GRCh38:
Chr2:240868893
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
14.
GRCh37:
Chr2:241808314-241808315
GRCh38:
Chr2:240868897-240868898
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
15.
GRCh37:
Chr2:241808314
GRCh38:
Chr2:240868897
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
16.
GRCh37:
Chr2:241808314
GRCh38:
Chr2:240868897
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
17.
GRCh37:
Chr2:241808314
GRCh38:
Chr2:240868897
AGXTPrimary hyperoxaluria, type I, not specified, Primary hyperoxaluria
Conflicting interpretations of pathogenicity
(Jun 14, 2016)
criteria provided, conflicting interpretations
18.
GRCh37:
Chr2:241808315
GRCh38:
Chr2:240868898
AGXTPrimary hyperoxaluria, type IPathogenic/Likely pathogenic
(Nov 27, 2014)
criteria provided, single submitter
19.
GRCh37:
Chr2:241808315
GRCh38:
Chr2:240868898
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
20.
GRCh37:
Chr2:241808317
GRCh38:
Chr2:240868900
AGXTPrimary hyperoxaluria, type I, Primary hyperoxaluriaUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
21.
GRCh37:
Chr2:241808347
GRCh38:
Chr2:240868930
AGXTPrimary hyperoxaluria, type I, not specified, Primary hyperoxaluria
Conflicting interpretations of pathogenicity
(Jun 22, 2016)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr2:241808356
GRCh38:
Chr2:240868939
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
23.
GRCh37:
Chr2:241808359
GRCh38:
Chr2:240868942
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
24.
GRCh37:
Chr2:241808365
GRCh38:
Chr2:240868948
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
25.
GRCh37:
Chr2:241808388
GRCh38:
Chr2:240868971
AGXTPrimary hyperoxaluria, type IPathogenic/Likely pathogenic
(Nov 27, 2014)
criteria provided, single submitter
26.
GRCh37:
Chr2:241808389
GRCh38:
Chr2:240868972
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
27.
GRCh37:
Chr2:241808398-241808399
GRCh38:
Chr2:240868981-240868982
AGXTPrimary hyperoxaluria, type IPathogenic/Likely pathogenic
(Jun 3, 2016)
criteria provided, single submitter
28.
GRCh37:
Chr2:241808403
GRCh38:
Chr2:240868986
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
29.
GRCh37:
Chr2:241808404
GRCh38:
Chr2:240868987
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
30.
GRCh37:
Chr2:241808404
GRCh38:
Chr2:240868987
AGXTPrimary hyperoxaluria, type IPathogenic/Likely pathogenic
(Nov 27, 2014)
criteria provided, single submitter
31.
GRCh37:
Chr2:241808407
GRCh38:
Chr2:240868990
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
32.
GRCh37:
Chr2:241808408
GRCh38:
Chr2:240868991
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
33.
GRCh37:
Chr2:241808412
GRCh38:
Chr2:240868995
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
34.
GRCh37:
Chr2:241808421
GRCh38:
Chr2:240869004
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
35.
GRCh37:
Chr2:241808459
GRCh38:
Chr2:240869042
AGXTPrimary hyperoxaluriaUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
36.
GRCh37:
Chr2:241808463
GRCh38:
Chr2:240869046
AGXTPrimary hyperoxaluria, type I, not specifiedConflicting interpretations of pathogenicity
(Nov 27, 2014)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr2:241808466-241808539
GRCh38:
Chr2:240869049-240869122
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
38.
GRCh37:
Chr2:241808487
GRCh38:
Chr2:240869070
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
39.
GRCh37:
Chr2:241808491
GRCh38:
Chr2:240869074
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
40.
GRCh37:
Chr2:241808530
GRCh38:
Chr2:240869113
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
41.
GRCh37:
Chr2:241808531
GRCh38:
Chr2:240869114
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
42.
GRCh37:
Chr2:241808533
GRCh38:
Chr2:240869116
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
43.
GRCh37:
Chr2:241808539-241808540
GRCh38:
Chr2:240869122-240869123
AGXTnot specifiedBenigncriteria provided, single submitter
44.
GRCh37:
Chr2:241808540
GRCh38:
Chr2:240869123
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
45.
GRCh37:
Chr2:241808573
GRCh38:
Chr2:240869156
AGXTPrimary hyperoxaluria, type I, not specifiedConflicting interpretations of pathogenicity
(Nov 27, 2014)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr2:241808586
GRCh38:
Chr2:240869169
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
47.
GRCh37:
Chr2:241808588
GRCh38:
Chr2:240869171
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
48.
GRCh37:
Chr2:241808596
GRCh38:
Chr2:240869179
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
49.
GRCh37:
Chr2:241808608
GRCh38:
Chr2:240869191
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
50.
GRCh37:
Chr2:241808619
GRCh38:
Chr2:240869202
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
51.
GRCh37:
Chr2:241808626
GRCh38:
Chr2:240869209
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
52.
GRCh37:
Chr2:241808630
GRCh38:
Chr2:240869213
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
53.
GRCh37:
Chr2:241808636
GRCh38:
Chr2:240869219
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
54.
GRCh37:
Chr2:241808642-241808648
GRCh38:
Chr2:240869225-240869231
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
55.
GRCh37:
Chr2:241808663
GRCh38:
Chr2:240869246
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
56.
GRCh37:
Chr2:241808663
GRCh38:
Chr2:240869246
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
57.
GRCh37:
Chr2:241808665
GRCh38:
Chr2:240869248
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
58.
GRCh37:
Chr2:241808666
GRCh38:
Chr2:240869249
AGXTPrimary hyperoxaluria, type IPathogenic/Likely pathogenic
(Mar 7, 2016)
criteria provided, single submitter
59.
GRCh37:
Chr2:241808669
GRCh38:
Chr2:240869252
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
60.
GRCh37:
Chr2:241808675
GRCh38:
Chr2:240869258
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
61.
GRCh37:
Chr2:241808685
GRCh38:
Chr2:240869268
AGXTPrimary hyperoxaluria, type I, not specified, Primary hyperoxaluria
Conflicting interpretations of pathogenicity
(Jun 14, 2016)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr2:241808697
GRCh38:
Chr2:240869280
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
63.
GRCh37:
Chr2:241808704-241808706
GRCh38:
Chr2:240869287-240869289
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
64.
GRCh37:
Chr2:241808704
GRCh38:
Chr2:240869287
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
65.
GRCh37:
Chr2:241808717
GRCh38:
Chr2:240869300
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
66.
GRCh37:
Chr2:241808720-241808728
Chr2:241808729
GRCh38:
Chr2:240869303-240869311
Chr2:240869312
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
67.
GRCh37:
Chr2:241808723
GRCh38:
Chr2:240869306
AGXTPrimary hyperoxaluria, type IPathogenic/Likely pathogenic
(Nov 27, 2014)
criteria provided, single submitter
68.
GRCh37:
Chr2:241808743
GRCh38:
Chr2:240869326
AGXTPrimary hyperoxaluria, type IPathogenic/Likely pathogenic
(Nov 27, 2014)
criteria provided, single submitter
69.
GRCh37:
Chr2:241808744
GRCh38:
Chr2:240869327
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
70.
GRCh37:
Chr2:241808745
GRCh38:
Chr2:240869328
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
71.
GRCh37:
Chr2:241808747
GRCh38:
Chr2:240869330
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
72.
GRCh37:
Chr2:241808748
GRCh38:
Chr2:240869331
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
73.
GRCh37:
Chr2:241808752
GRCh38:
Chr2:240869335
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
74.
GRCh37:
Chr2:241808753
GRCh38:
Chr2:240869336
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
75.
GRCh37:
Chr2:241808756
GRCh38:
Chr2:240869339
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
76.
GRCh37:
Chr2:241808767
GRCh38:
Chr2:240869350
AGXTPrimary hyperoxaluria, type IPathogenic/Likely pathogenic
(Nov 27, 2014)
criteria provided, single submitter
77.
GRCh37:
Chr2:241808770
GRCh38:
Chr2:240869353
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
78.
GRCh37:
Chr2:241808773
GRCh38:
Chr2:240869356
AGXTPrimary hyperoxaluria, type I, not specifiedConflicting interpretations of pathogenicity
(Dec 22, 2015)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr2:241808774
GRCh38:
Chr2:240869357
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
80.
GRCh37:
Chr2:241808780
GRCh38:
Chr2:240869363
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
81.
GRCh37:
Chr2:241808781
GRCh38:
Chr2:240869364
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
82.
GRCh37:
Chr2:241808792
GRCh38:
Chr2:240869375
AGXTPrimary hyperoxaluria, type I, not specified, Primary hyperoxaluria
Conflicting interpretations of pathogenicity
(Jun 14, 2016)
criteria provided, conflicting interpretations
83.
GRCh37:
Chr2:241808835-241808843
GRCh38:
Chr2:240869418-240869426
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
84.
GRCh37:
Chr2:241810057-241810081
GRCh38:
Chr2:240870640-240870664
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
85.
GRCh37:
Chr2:241810066
GRCh38:
Chr2:240870649
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
86.
GRCh37:
Chr2:241810073
GRCh38:
Chr2:240870656
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
87.
GRCh37:
Chr2:241810087
GRCh38:
Chr2:240870670
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
88.
GRCh37:
Chr2:241810111
GRCh38:
Chr2:240870694
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
89.
GRCh37:
Chr2:241810118-241810120
GRCh38:
Chr2:240870701-240870703
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
90.
GRCh37:
Chr2:241810125
GRCh38:
Chr2:240870708
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
91.
GRCh37:
Chr2:241810154
GRCh38:
Chr2:240870737
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
92.
GRCh37:
Chr2:241810161
GRCh38:
Chr2:240870744
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
93.
GRCh37:
Chr2:241810170
GRCh38:
Chr2:240870753
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
94.
GRCh37:
Chr2:241810750
GRCh38:
Chr2:240871333
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
95.
GRCh37:
Chr2:241810754
GRCh38:
Chr2:240871337
AGXTPrimary hyperoxaluria, type IUncertain significance
(Nov 27, 2014)
no assertion criteria provided
96.
GRCh37:
Chr2:241810764
GRCh38:
Chr2:240871347
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
97.
GRCh37:
Chr2:241810787
GRCh38:
Chr2:240871370
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
98.
GRCh37:
Chr2:241810789-241810796
GRCh38:
Chr2:240871372-240871379
AGXTPrimary hyperoxaluria, type IPathogenic
(Jan 18, 2016)
criteria provided, single submitter
99.
GRCh37:
Chr2:241810791
GRCh38:
Chr2:240871374
AGXTPrimary hyperoxaluria, type IPathogenic
(Nov 27, 2014)
no assertion criteria provided
100.
GRCh37:
Chr2:241810796
GRCh38:
Chr2:240871379
AGXTPrimary hyperoxaluria, type IPathogenic
(May 11, 2016)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by

Download:

Choose Destination
Support Center